Lee M R
University of Edinburgh, Edinburgh, UK.
J R Coll Physicians Edinb. 2011 Mar;41(1):78-84. doi: 10.4997/JRCPE.2011.116.
Ephedra is a Chinese shrub which has been used in China for medicinal purposes for several thousand years. The pure alkaloid ephedrine was first isolated and characterised by Nagai in 1885. It was then forgotten until it was rediscovered by Chen and Schmidt in the early 1920s. Its actions on the adrenoceptors could be classified into separate alpha and beta effects--a defining moment in the history of autonomic pharmacology. Ephedrine became a highly popular and effective treatment for asthma, particularly because, unlike adrenaline (until then the standard therapy), it can be given by mouth. Ephedrine as a treatment for asthma reached its zenith in the late 1950s, since when there has been a gradual and inevitable decline in its therapeutic use. From mainstream medicine, ephedrine moved into the twilight zone of street drugs and nutritional supplements. Ephedra and ephedrine products are now banned in many countries, as they are a major source for the production of the addictive compound methamphetamine (crystal meth).
麻黄是一种中国灌木,在中国已被用于药用目的数千年。纯生物碱麻黄碱于1885年首次由长井分离并鉴定。此后它被遗忘,直到20世纪20年代初被陈和施密特重新发现。它对肾上腺素能受体的作用可分为单独的α和β效应——这是自主神经药理学史上的一个决定性时刻。麻黄碱成为一种非常流行且有效的哮喘治疗药物,特别是因为,与肾上腺素(直到那时的标准疗法)不同,它可以口服。麻黄碱作为哮喘治疗药物在20世纪50年代末达到顶峰,从那时起其治疗用途逐渐且不可避免地减少。从主流医学中,麻黄碱进入了街头毒品和营养补充剂的边缘地带。麻黄和麻黄碱产品现在在许多国家被禁止,因为它们是成瘾性化合物甲基苯丙胺(冰毒)生产的主要来源。